Analysis of Immune Escape from NK cell in Melanoma
Analysis of Immune Escape from NK cell in Melanoma
批准号:
14570812
负责人:
KAGESHITA Toshiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One of the larger concernsin melanoma T cell based immunotherapy is the immune escape phenomenon resulting from loss of melanoma associated antigens and/or HLA class I. The head investigator has been analyzing the mechanisms of down regulation of HLA class I in melanocytic cells.HLA class I was down regulated in melanoma lesions, which results in no T cell infiltration in such lesions. Theoretically loss of HLA class I in melanoma cells allows NK cell infiltration. However, most of the melanoma lesions show neither T cell nor NK cell infiltration. These data suggest that melanoma cells can escape from NK cell attack.In the present study, analysis of immune escape from NK cell in melanoma was investigated using monoclonal antibodies to MHC class I chain-related molecule A and B (MICA and MICB), which are ligands for the newly cloned NK cell activating receptor NKG2D.The head investigator found the following points :1)Expression of MICA in culture human melanoma cell linesTen of 16 human … More melanoma cell lines were shown to be MICA positive by ELISA.2)Expression of MICA in melanocytic tumorsExpression of MICA in melanocytic lesions was investigated immunohistochemically using frozen melanocytic nevus, and primary and metastatic melanoma lesions. MICA was not expressed in melanocytic nevus, however it was expressed in melanoma lesions. MICA was expressed in 30%, 60%, and 20% of radial growth phase, vertical growth phase, and metastatic lesions, respectively.3)Selection of monoclonal antibody to MICB which can react with formalin-fixed tissue sectionThe monoclonal antibody to MICA did not react with formalin-fixed tissue sections. Therefore, I tried to find a monoclonal antibody to MICB which can react with formalin-fixed tissue section from more than 10 antibodies to MICB. We were able to select one antibody to MICB that could react with formalin-fixed tissue sections using the retrieval antigen method.These data will facilitate the analysis of immune escape from NK cell in melanoma and further research project is under going at my laboratory. Less
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Maldonado JL.: "Deretminants of BRAF mutations in primary melaomas"J.Natl.Cancer Inst.. 95. 1878-1890 (2003)
Maldonado JL.:“原发性黑色素瘤中 BRAF 突变的决定因素”J.Natl.Cancer Inst.. 95. 1878-1890 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oka M, Kageshita T, Ono T, Goto A, Kuroki T, Ichihashi M.: "Protein kinase C α associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-indepemdent manner in human melanoma cells."J Invest Dermatol.. 121. 6
Oka M、Kageshita T、Ono T、Goto A、Kuroki T、Ichihashi M.:“蛋白激酶 C α 与磷脂酶 D1 结合,并以与蛋白磷酸化无关的方式增强人类黑色素瘤细胞中基础磷脂酶 D 的活性。”J Invest Dermatol .. 121. 6
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oka M.: "Protein kinase C α associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-indepemdent manner in human melanoma cells"J Invest Dermatol.. 121. 69-76 (2003)
Oka M.:“蛋白激酶 C α 与磷脂酶 D1 结合,并以与蛋白磷酸化无关的方式增强人类黑色素瘤细胞中的基础磷脂酶 D 活性”J Invest Dermatol.. 121. 69-76 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kageshita T, Inoue Y, Ono T.: "Spontaneous regression of congenital melanocytic nevi without evidence of halo phenomenon."Dermatology. 207. 193-195 (2003)
Kageshita T、Inoue Y、Ono T.:“先天性黑素细胞痣的自发消退,没有晕圈现象的证据。”皮肤科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishihara T, Kageshita T, Matsushita S, Ono T.: "Investigation of sentinel lymph nodes of the axillary and cubital regions in upper-extremity malignant skin tumors : a series of 15 patients."Int.J.Clin.Oncol.. 8. 297-300 (2003)
Ishihara T、Kageshita T、Matsushita S、Ono T.:“上肢恶性皮肤肿瘤腋窝和肘部前哨淋巴结的调查:一系列 15 名患者。”Int.J.Clin.Oncol.. 8
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Molecular-based analysis of HLA class I processing machinery defects in human melanoma
-
批准号:16591106
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:KAGESHITA Toshiro
-
依托单位:
Analysis of Immune Escape from Melanoma Peptide Vaccine Therapy
-
批准号:12670828
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:KAGESHITA Toshiro
-
依托单位:
STUDY ON MACHINERY HLA CLASS I DOWNREGULATION ON MELANOMA CELLS.
-
批准号:09670888
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1997
-
负责人:KAGESHITA Toshiro
-
依托单位:
ANALYSIS OF MELANOMA IDIOTYPE NETWORK AND IT'S APPLICATION FOR VACCINE THERAPY.
-
批准号:07670952
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:KAGESHITA Toshiro
-
依托单位:
ANALYSIS OF MELANOMA IDIOTYPE NETWORK AND IT'S CLINICAL APPLICATION
-
批准号:05670735
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:KAGESHITA Toshiro
-
依托单位:
RESEARCH FOR CLINICAL APPLICATION OF ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES.
-
批准号:02670483
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1990
-
负责人:KAGESHITA Toshiro
-
依托单位:
海外基金